SOURCE: IDenta Corp.

October 29, 2007 10:40 ET

International Drug & Explosives Detection Company IDenta Releases Progress Report for U.S. Operations -- Accutest®-IDenta Partnership on Track for Market Leadership in 2008

JERUSALEM--(Marketwire - October 29, 2007) - IDenta Corp. (PINKSHEETS: IDTA) today released a summary detailing the progress that has been made between the company and its U.S. partnership with Jant Pharmacal - Accutest®. The partnership has been in full effect for approximately six months during which time the two companies have engaged in an almost total overhaul of the company's U.S. domestic sales strategy.

"The IDenta-Accutest® partnership is now on a fast track for producing record sales of IDenta's drug detection and explosive detection products," said IDTA CEO Yaacov Shoham. "One year ago IDenta was still working to engage the right national sales force, but today I'm happy to announce that IDenta-Accutest has sales representation in every state. At the present time there are over 100 people involved with the marketing and sales of IDenta Stinger Drug Detection kits in the U.S. I can say without a doubt that we have truly found and developed the right sales and marketing partnership with the outstanding team of executives at Jant Pharmacal - Accutest®."

"The partnership's first strategy has been to focus on targeting law enforcement agencies. In the past six months the numbers of these new customers and sales are growing rapidly. Therefore we expect to announce the annualized sales figures will be released early in the second quarter of 2008," continued Shoham.

To achieve this new distributorship network the entire IDenta sales and marketing process has undergone significant and crucial changes including:

1) Redesigning the drug testing kit packaging to include the Accutest®-IDenta brand name.

2) Modifying the actual kits to make them more user friendly and secure, while at the same time leaving the company's patented chemical processes unchanged.

3) The two organizations have mapped the entire U.S. into specific territories to now have representatives, distributors and agents in every region.

4) They have developed a new arsenal of marketing and website sales tools. Each of the representatives have a complete set of these tools, and are distributing a large number of product samplings many of which are currently being tested across the country by various law enforcement agencies.

5) Developed a comprehensive training system for distributors, representatives, agents. Accutest® has conducted training sessions around the country and in many cases has selected new personnel with local, state, federal law enforcement experience.

6) Initiated a nationwide direct mail program targeted at providing law enforcement officials both product information and the names of their local representatives. The company partnership has also started advertising in a number of industry trade publications.

7) Accutest® has attended a number of industry trade shows exposing their new product line to thousands of law enforcement and civilian safety officials. Both IDenta and Accutest officials will be at the upcoming California Narcotics Agents meeting in mid-November in Reno, Nevada.

"The reaction from the our network of distributors, reps and agents has been overwhelming because many of them have experience with the current used drug detectors and were not at all happy with the way our competitor's test kits were administered. The Accutest®-IDenta partnership in just six months has so far been a huge success for our marketing program, and we are now integrating a number of these procedures into our other operations world-wide where we continue to also experience great strides with our sales and marketing programs," concluded Shoham.

ABOUT JANT PHARMACAL CORPORATION

Jant Pharmacal Corporation is recognized as an industry leader in the diagnostics industry. Established in 1986, Jant provides a comprehensive line of rapid immuno-diagnostic test products for legal, law enforcement, clinical, consumer, and workplace applications including saliva and urine drug tests, alcohol tests, tobacco tests and pregnancy & fertility tests.

Products are marketed under Jant's proprietary labels, including Accutest® and Accustrip®, through national and international distributors, as well as through client private labels.

For more information about the Accutest®-IDenta product line please
contact:
Mr. Eyal Golan, COO
JANT PHARMACAL CORPORATION
16255 Ventura Blvd. #505
Encino, CA 91436
Toll Free: 800-676-5565
www.accutest.net

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug detection kits and most recently explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz.

Contact:

For Investor Relations, lobbying interests or information concerning
IDenta's products internationally contact:

Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
     +972-8-9716874
Fax: +972-8-9716875
fpi@drugsdetector.com

For Investor Relations in the United States contact:
Randy Jacobs
US Corporate Spokesman
IDentaNews@sitcomllc.com
1-800-316-9437

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • Contact:
    For Investor Relations, lobbying interests or information concerning
    IDenta's products internationally contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    +972-8-9716874
    Fax: +972-8-9716875
    fpi@drugsdetector.com

    For Investor Relations in the United States contact:
    Randy Jacobs
    US Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437

    For more information about the Accutest®-IDenta product line please
    contact:
    Mr. Eyal Golan
    COO
    JANT PHARMACAL CORPORATION
    16255 Ventura Blvd. #505
    Encino, CA 91436
    Toll Free: 800-676-5565
    www.accutest.net